Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma

Cellular and Molecular Immunology

Volumn 9, Issue 1, 2012, Pages 7-8

  Hu, Zhiqing ^a   Zhao, Weihua ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN; COPPER; ESTRADIOL; FATTY ACID; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 122; MICRORNA 214; NICKEL; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CUT LIKE HOMEOBOX 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; CANCER CELL; CANCER DIAGNOSIS; CANCER GRADING; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULAR MECHANICS; MORPHOGENESIS; NONHUMAN; NOTE; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 84855393609     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.30     Document Type: Note

References (11)

1. Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, Akanuma M et al. MicroRNA122 is a key regulator of a-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2011; 2: 338.
2. Subramanyam D, Blelloch R. From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev 2011; 21: 1-6.
3. Lewis AP, Jopling CL. Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans 2010; 38: 1553-1557.
4. NCBI. Alpha-fetoprotein. Gene ID: 174 updated on 5 Jun 2011. Available from: http://www.ncbi.nlm.nih. gov/sites/entrez.
5. Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010; 56: e1-e48.
6. Sansregret L, Nepveu A. The multiple roles of CUX1: insights from mouse models and cell-based assays. Gene 2008; 412: 84-94.
7. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002; 2: 133-142.
8. Xie Z, Zhang H, Tsai W, Zhang Y, Du Y, Zhong J et al. Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver. Proc Natl Acad Sci USA 2008; 105: 10859-10864.
9. Houwert AC, Giltay JC, Lentjes EG, Lock MT. Hereditary persistence of alpha-fetoprotein (HPAFP): review of the literature. Neth J Med 2010; 68: 354-358.
10. Carr BI, Pancoska P, Branch RA. Low alpha-fetoprotein hepatocellular carcinoma. J Gastroenterol Hepatol 2010; 25: 1543-1549.
11. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99: 671-678. (Pubitemid 44521987)